Carrassa L - Search Results

1

The Role of the Hedgehog Pathway in Cholangiocarcinoma.

Anichini G, Carrassa L, Stecca B, Marra F, Raggi C. Anichini G, et al. Among authors: carrassa l. Cancers (Basel). 2021 Sep 24;13(19):4774. doi: 10.3390/cancers13194774. Cancers (Basel). 2021. PMID: 34638259 Free PMC article. Review.

2

Identification of PLK1 as a New Therapeutic Target in Mucinous Ovarian Carcinoma.

Affatato R, Carrassa L, Chilà R, Lupi M, Restelli V, Damia G. Affatato R, et al. Among authors: carrassa l. Cancers (Basel). 2020 Mar 13;12(3):672. doi: 10.3390/cancers12030672. Cancers (Basel). 2020. PMID: 32183025 Free PMC article.

3

Targeting non-canonical activation of GLI1 by the SOX2-BRD4 transcriptional complex improves the efficacy of HEDGEHOG pathway inhibition in melanoma.

Pietrobono S, Gaudio E, Gagliardi S, Zitani M, Carrassa L, Migliorini F, Petricci E, Manetti F, Makukhin N, Bond AG, Paradise BD, Ciulli A, Fernandez-Zapico ME, Bertoni F, Stecca B. Pietrobono S, et al. Among authors: carrassa l. Oncogene. 2021 Jun;40(22):3799-3814. doi: 10.1038/s41388-021-01783-9. Epub 2021 May 6. Oncogene. 2021. PMID: 33958721 Free PMC article.

4

Novel Therapeutic Approaches with DNA Damage Response Inhibitors for Melanoma Treatment.

Maresca L, Stecca B, Carrassa L. Maresca L, et al. Among authors: carrassa l. Cells. 2022 Apr 26;11(9):1466. doi: 10.3390/cells11091466. Cells. 2022. PMID: 35563772 Free PMC article. Review.

5

Combined Inhibition of Smoothened and the DNA Damage Checkpoint WEE1 Exerts Antitumor Activity in Cholangiocarcinoma.

Anichini G, Raggi C, Pastore M, Carrassa L, Maresca L, Crivaro E, Lottini T, Duwe L, Andersen JB, Tofani L, Di Tommaso L, Banales JM, Arcangeli A, Marra F, Stecca B. Anichini G, et al. Among authors: carrassa l. Mol Cancer Ther. 2023 Mar 2;22(3):343-356. doi: 10.1158/1535-7163.MCT-22-0379. Mol Cancer Ther. 2023. PMID: 36807728 Free PMC article.

6

Targeting the DNA damage response for patients with lymphoma: Preclinical and clinical evidences.

Carrassa L, Colombo I, Damia G, Bertoni F. Carrassa L, et al. Cancer Treat Rev. 2020 Nov;90:102090. doi: 10.1016/j.ctrv.2020.102090. Epub 2020 Aug 19. Cancer Treat Rev. 2020. PMID: 32892059 Free article. Review.

7

Characterization of the 5'flanking region of the human Chk1 gene: identification of E2F1 functional sites.

Carrassa L, Broggini M, Vikhanskaya F, Damia G. Carrassa L, et al. Cell Cycle. 2003 Nov-Dec;2(6):604-9. Cell Cycle. 2003. PMID: 14504477

8

Chk1, but not Chk2, is involved in the cellular response to DNA damaging agents: differential activity in cells expressing or not p53.

Carrassa L, Broggini M, Erba E, Damia G. Carrassa L, et al. Cell Cycle. 2004 Sep;3(9):1177-81. Epub 2004 Sep 13. Cell Cycle. 2004. PMID: 15326376

9

Checkpoint kinase 1 down-regulation by an inducible small interfering RNA expression system sensitized in vivo tumors to treatment with 5-fluorouracil.

Ganzinelli M, Carrassa L, Crippa F, Tavecchio M, Broggini M, Damia G. Ganzinelli M, et al. Among authors: carrassa l. Clin Cancer Res. 2008 Aug 15;14(16):5131-41. doi: 10.1158/1078-0432.CCR-08-0304. Clin Cancer Res. 2008. PMID: 18698031

10

U2OS cells lacking Chk1 undergo aberrant mitosis and fail to activate the spindle checkpoint.

Carrassa L, Sanchez Y, Erba E, Damia G. Carrassa L, et al. J Cell Mol Med. 2009 Aug;13(8A):1565-76. doi: 10.1111/j.1582-4934.2009.00362.x. J Cell Mol Med. 2009. PMID: 19778378 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page